Marta Leiva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Marta Leiva has a total of 122 co-authors. Here are the top co-authors by number of shared publications:
- José Ríos
Universitat Autónoma de Barcelona
19 shared publications Daniel Costa
Servei d'Oftalmologia de la Fundació Hospital Clínic Veterinari, Facultat de Veterinària, Universitat Autònoma de Barcelona, Bellaterra, Barcelona, Spain
13 shared publicationsTeresa Peña
Departament de Medicina i Cirurgia Animal, Facultat de Veterinaria, Universitat Autònoma de Barcelona, Barcelona, Spain
13 shared publications- Teresa Peña
Servei d'Oftalmologia, Fundació Hospital Clínic Veterinari Universitat Autònoma de Barcelona Bellaterra Spain
13 shared publications Maria Teresa Peña
Fundació Hospital Clínic Veterinari, Campus Universitat Autònoma de Barcelona, Bellaterra, Spain
7 shared publicationsCarolina Naranjo
Idexx Laboratories, Barcelona, Spain
6 shared publications
Latest Publications
- 15 July 2026
- Published by Wiley in Veterinary Ophthalmology
- Vol. 29 (5) , e70226
Slit‐Lamp Evaluation Provides Greater Depth Estimates in Stromal Ulcers Than High‐Resolution Ultrasonic Biomicroscopy: A Prospective Study in 50 Dogs
Purpose: To compare the estimation of corneal stromal ulcer depth (UD) by slit‐lamp biomicroscopy (SLB) and ultrasound biomicroscopy (UBM) images, to identify factors influencing surgical decision‐making, and to evaluate whether decisions based on SLB images change after reviewing UBM depth measurements. Methods: Fifty dogs with corneal stromal ulceration were included. SLB and UBM images of the deepest part of each ulcer were obtained. Three masked external examiners estimated UD percentage using the SLB images. Clinical records were reviewed, and a questionnaire evaluated whether surgery was recommended and which factors influenced that decision. Finally, UBM images with depth measurements were provided, and examiners were asked whether this information altered their initial surgical recommendation. Results: Median UD estimated by the evaluators was 63.3% (interquartile range [IQR]: 40.0–78.7), which was significantly higher than the UD measured by UBM (42.1%; IQR: 30.2–55.9; p < 0.001). The mean absolute percentage difference in UD% between SLB estimates and UBM measurements (relative to UBM) was 38.7%. This difference was evident in both anterior and medium stromal ulcers ( p < 0.001). The factors most frequently influencing surgical decision‐making were UD (84.0%–92.0%) and ulcer width (36.0%–52.0%). After reviewing the UBM images, evaluators modified their initial medical versus surgical recommendation in 10.0%–14.0% of cases, most commonly changing from surgery to medical management. Conclusion: The SLB tended to provide higher UD% estimates than UBM, with a mean absolute percentage difference of 38.7% (relative to UBM), particularly in anterior and medium stromal ulcers. UD and ulcer width drive surgical decisions. UBM provides the necessary precision that may help refine surgical indication and avoid unnecessary corneal surgery.
- 15 July 2026
- Published by Wiley in Veterinary Ophthalmology
- Vol. 29 (5) , e70226
Slit‐Lamp Evaluation Provides Greater Depth Estimates in Stromal Ulcers Than High‐Resolution Ultrasonic Biomicroscopy: A Prospective Study in 50 Dogs
Purpose: To compare the estimation of corneal stromal ulcer depth (UD) by slit‐lamp biomicroscopy (SLB) and ultrasound biomicroscopy (UBM) images, to identify factors influencing surgical decision‐making, and to evaluate whether decisions based on SLB images change after reviewing UBM depth measurements. Methods: Fifty dogs with corneal stromal ulceration were included. SLB and UBM images of the deepest part of each ulcer were obtained. Three masked external examiners estimated UD percentage using the SLB images. Clinical records were reviewed, and a questionnaire evaluated whether surgery was recommended and which factors influenced that decision. Finally, UBM images with depth measurements were provided, and examiners were asked whether this information altered their initial surgical recommendation. Results: Median UD estimated by the evaluators was 63.3% (interquartile range [IQR]: 40.0–78.7), which was significantly higher than the UD measured by UBM (42.1%; IQR: 30.2–55.9; p < 0.001). The mean absolute percentage difference in UD% between SLB estimates and UBM measurements (relative to UBM) was 38.7%. This difference was evident in both anterior and medium stromal ulcers ( p < 0.001). The factors most frequently influencing surgical decision‐making were UD (84.0%–92.0%) and ulcer width (36.0%–52.0%). After reviewing the UBM images, evaluators modified their initial medical versus surgical recommendation in 10.0%–14.0% of cases, most commonly changing from surgery to medical management. Conclusion: The SLB tended to provide higher UD% estimates than UBM, with a mean absolute percentage difference of 38.7% (relative to UBM), particularly in anterior and medium stromal ulcers. UD and ulcer width drive surgical decisions. UBM provides the necessary precision that may help refine surgical indication and avoid unnecessary corneal surgery.
- Open Access
- 1 July 2026
- Published by Wiley in Veterinary Ophthalmology
- Vol. 29 (4) , e70219
Ocular Manifestations in Dogs With Facial Nerve Dysfunction
Objective: To characterize the spectrum and frequency of ocular abnormalities associated with facial nerve dysfunction (FND) in dogs and to assess clinical outcomes, with specific comparison between brachycephalic (BC) and non‐brachycephalic (NBC) breeds: Methods: Medical records of dogs with FND evaluated between 2009 and 2023 at the Ophthalmology Service of the Hospital Clínic Veterinari, Universitat Autònoma de Barcelona, were retrospectively reviewed. Results: Seventy‐four dogs (84 eyes) were included, with French Bulldog being the most frequently affected breed (20; 27.0%). Facial nerve paralysis affected 63.1% of eyes, whereas paresis affected 36.9%. The main etiologies were idiopathic (14.9%), iatrogenic (13.5%), and otitis media/interna (12.2%). Corneal sensitivity and Schirmer tear test I were significantly reduced in affected eyes, without significant differences between skull types. Ulcerative keratitis occurred in 61.9% of eyes, being more frequent and severe in BC dogs ( p = 0.007). Facial function recovered in 47.6% of dogs. Recovery was unaffected by age or skull type, differed significantly by sex ( p = 0.043), and tended to be higher in dogs with paresis ( p = 0.075). Worse ocular outcomes were linked to lower esthesiometry values ( p = 0.023) and to the presence of anterior uveitis ( p = 0.037). At the end of the study, 14 eyes (17.6%) were enucleated. Conclusions: FND carries a guarded prognosis in dogs, with fewer than half achieving functional recovery. Ocular surface disorders, particularly neurogenic keratoconjunctivitis sicca and neuroparalytic ulcerative keratitis, were frequent and often led to poor outcomes, especially in BC dogs. Early ophthalmic management is crucial to preserve vision.
- 1 July 2026
- Published by Wiley in Veterinary Ophthalmology
- Vol. 29 (4) , e70219
Open AccessOcular Manifestations in Dogs With Facial Nerve Dysfunction
Objective: To characterize the spectrum and frequency of ocular abnormalities associated with facial nerve dysfunction (FND) in dogs and to assess clinical outcomes, with specific comparison between brachycephalic (BC) and non‐brachycephalic (NBC) breeds: Methods: Medical records of dogs with FND evaluated between 2009 and 2023 at the Ophthalmology Service of the Hospital Clínic Veterinari, Universitat Autònoma de Barcelona, were retrospectively reviewed. Results: Seventy‐four dogs (84 eyes) were included, with French Bulldog being the most frequently affected breed (20; 27.0%). Facial nerve paralysis affected 63.1% of eyes, whereas paresis affected 36.9%. The main etiologies were idiopathic (14.9%), iatrogenic (13.5%), and otitis media/interna (12.2%). Corneal sensitivity and Schirmer tear test I were significantly reduced in affected eyes, without significant differences between skull types. Ulcerative keratitis occurred in 61.9% of eyes, being more frequent and severe in BC dogs ( p = 0.007). Facial function recovered in 47.6% of dogs. Recovery was unaffected by age or skull type, differed significantly by sex ( p = 0.043), and tended to be higher in dogs with paresis ( p = 0.075). Worse ocular outcomes were linked to lower esthesiometry values ( p = 0.023) and to the presence of anterior uveitis ( p = 0.037). At the end of the study, 14 eyes (17.6%) were enucleated. Conclusions: FND carries a guarded prognosis in dogs, with fewer than half achieving functional recovery. Ocular surface disorders, particularly neurogenic keratoconjunctivitis sicca and neuroparalytic ulcerative keratitis, were frequent and often led to poor outcomes, especially in BC dogs. Early ophthalmic management is crucial to preserve vision.
- Open Access
- 9 May 2026
- Published by MDPI AG in Veterinary Sciences
- Vol. 13 (5) , 461
Beyond Antibiotics: The Expanding Role of Non-Antibiotic Therapies in Veterinary Ophthalmology
The sustained increase in bacterial resistance has driven the search for therapeutic alternatives that may help reduce antibiotic use, particularly in empirical treatments. In this context, topical ophthalmic antiseptics have emerged as effective and safe tools, suitable for both perioperative prophylaxis and the management of mild or superficial ocular diseases. Their broad spectrum of activity—encompassing bacteria, fungi, viruses, and protozoa—together with the low likelihood of inducing resistance, establishes them as valuable partners in daily clinical practice. This article reviews the current evidence on the use of antiseptics in veterinary ophthalmology, focusing on their clinical applications, therapeutic benefits, and limitations. It also highlights the need for further studies to establish species-specific, disease-specific, and context-based protocols.
- 9 May 2026
- Published by MDPI AG in Veterinary Sciences
- Vol. 13 (5) , 461
Open AccessBeyond Antibiotics: The Expanding Role of Non-Antibiotic Therapies in Veterinary Ophthalmology
The sustained increase in bacterial resistance has driven the search for therapeutic alternatives that may help reduce antibiotic use, particularly in empirical treatments. In this context, topical ophthalmic antiseptics have emerged as effective and safe tools, suitable for both perioperative prophylaxis and the management of mild or superficial ocular diseases. Their broad spectrum of activity—encompassing bacteria, fungi, viruses, and protozoa—together with the low likelihood of inducing resistance, establishes them as valuable partners in daily clinical practice. This article reviews the current evidence on the use of antiseptics in veterinary ophthalmology, focusing on their clinical applications, therapeutic benefits, and limitations. It also highlights the need for further studies to establish species-specific, disease-specific, and context-based protocols.
- Open Access
- 26 March 2026
- Published by MDPI AG in Preprints.org
Beyond Antibiotics: The Emerging Role of Antiseptics in Veterinary Ophthalmology
The sustained increase in bacterial resistance has driven the search for therapeutic alternatives that may help reduce antibiotic use, particularly in empirical treatments. In this context, topical ophthalmic antiseptics have emerged as effective and safe tools, suitable for both perioperative prophylaxis and the management of mild or superficial ocular diseases. Their broad spectrum of activity -encompassing bacteria, fungi, viruses, and protozoa- together with the low likelihood of inducing resistance, establishes them as valuable partners in daily clinical practice. This article reviews the current evidence on the use of antiseptics in veterinary ophthalmology, focusing on their clinical applications, therapeutic benefits, and limitations. It also highlights the need for further studies to establish species-specific, disease-specific, and context-based protocols.
- 26 March 2026
- Published by MDPI AG in Preprints.org
Open AccessBeyond Antibiotics: The Emerging Role of Antiseptics in Veterinary Ophthalmology
The sustained increase in bacterial resistance has driven the search for therapeutic alternatives that may help reduce antibiotic use, particularly in empirical treatments. In this context, topical ophthalmic antiseptics have emerged as effective and safe tools, suitable for both perioperative prophylaxis and the management of mild or superficial ocular diseases. Their broad spectrum of activity -encompassing bacteria, fungi, viruses, and protozoa- together with the low likelihood of inducing resistance, establishes them as valuable partners in daily clinical practice. This article reviews the current evidence on the use of antiseptics in veterinary ophthalmology, focusing on their clinical applications, therapeutic benefits, and limitations. It also highlights the need for further studies to establish species-specific, disease-specific, and context-based protocols.
- Open Access
- 2 October 2024
- Published by Wiley in Veterinary Ophthalmology
- Vol. 28 (2) , 532-542
Reconstruction of deep and perforating corneal defects in dogs—A review (Part II/III): Biomaterials and keratoprosthesis
The surgical reconstruction of severe corneal ulcers is a common and crucial component of the clinical practice of veterinary ophthalmology. Numerous surgical techniques are used in dogs for corneal reconstruction, and these techniques may be categorized by the material used to repair the corneal lesion. The first part of the present review described procedures that utilize autogenous ocular tissues, homologous donor tissues, and heterologous donor tissues. In this second part of the review, the categories of biomaterials and keratoprosthetics will be summarized. Biomaterials that are reported for use in dogs include amniotic membrane, porcine urinary bladder acellular matrix, porcine small intestinal submucosa, acellular porcine corneal stroma, and other miscellaneous soft tissue and cartilage grafts (e.g., preserved equine renal capsule, autologous omentum, autologous buccal mucosa membrane, bovine pericardium, and homologous peritoneum). Descriptions of keratoprosthesis surgery in dogs are currently limited, but the use of artificial corneal transplants hold promise for dogs with severe, vision‐compromising corneal disease that is not amenable to other reconstruction techniques. This review describes the results of experimental studies evaluating these graft materials in dogs, and it will summarize the findings and outcomes of the clinical articles published in each material category. Reporting inconsistencies and areas where additional research is required will be highlighted to help guide future studies in this area. A major aim of this review is to help identify potential subjects that could be evaluated in future investigations and that might lead to refinements in clinical practice.
- 2 October 2024
- Published by Wiley in Veterinary Ophthalmology
- Vol. 28 (2) , 532-542
Open AccessReconstruction of deep and perforating corneal defects in dogs—A review (Part II/III): Biomaterials and keratoprosthesis
The surgical reconstruction of severe corneal ulcers is a common and crucial component of the clinical practice of veterinary ophthalmology. Numerous surgical techniques are used in dogs for corneal reconstruction, and these techniques may be categorized by the material used to repair the corneal lesion. The first part of the present review described procedures that utilize autogenous ocular tissues, homologous donor tissues, and heterologous donor tissues. In this second part of the review, the categories of biomaterials and keratoprosthetics will be summarized. Biomaterials that are reported for use in dogs include amniotic membrane, porcine urinary bladder acellular matrix, porcine small intestinal submucosa, acellular porcine corneal stroma, and other miscellaneous soft tissue and cartilage grafts (e.g., preserved equine renal capsule, autologous omentum, autologous buccal mucosa membrane, bovine pericardium, and homologous peritoneum). Descriptions of keratoprosthesis surgery in dogs are currently limited, but the use of artificial corneal transplants hold promise for dogs with severe, vision‐compromising corneal disease that is not amenable to other reconstruction techniques. This review describes the results of experimental studies evaluating these graft materials in dogs, and it will summarize the findings and outcomes of the clinical articles published in each material category. Reporting inconsistencies and areas where additional research is required will be highlighted to help guide future studies in this area. A major aim of this review is to help identify potential subjects that could be evaluated in future investigations and that might lead to refinements in clinical practice.
- Open Access
- 1 October 2024
- Published by Wiley in Veterinary Ophthalmology
- Vol. 28 (2) , 519-531
Reconstruction of deep and perforating corneal defects in dogs—A review (Part I/III): Autogenous ocular tissues, donor tissues, and corneal clarity scoring
Corneal reconstruction is a key part of veterinary ophthalmic practice and numerous reconstructive techniques have been described for use in small animals in the peer‐reviewed veterinary literature written in English. Despite the evidence accrued over the last six decades in over 40 clinical articles and numerous other publications on ocular surface health, several key areas require further study. The comparison between studies is difficult due to elements that go beyond common factors, such as the indication for surgery, the reconstructive technique preferred by the surgeon or the availability of reconstructive materials. However, the differences in reporting style adopted by different authors between similar studies and the lack of data found in retrospective studies add to this complexity. The present review is divided into three parts. One covers the use of autologous materials for reconstruction and corneal transplants, as well as corneal clarity. A second part focuses on biomaterials and keratoprosthetics, while the third part focuses on the use of corneal sutures and report of ocular discomfort/pain in the veterinary literature. The review focuses on the main findings of each reconstruction technique. It aims to identify areas where key information about common procedures is missing so that general guidelines may be provided for the planning of patient record keeping and future retrospective or prospective studies, while it also aims to highlight the presence of knowledge gaps that deserve further attention.
- 1 October 2024
- Published by Wiley in Veterinary Ophthalmology
- Vol. 28 (2) , 519-531
Open AccessReconstruction of deep and perforating corneal defects in dogs—A review (Part I/III): Autogenous ocular tissues, donor tissues, and corneal clarity scoring
Corneal reconstruction is a key part of veterinary ophthalmic practice and numerous reconstructive techniques have been described for use in small animals in the peer‐reviewed veterinary literature written in English. Despite the evidence accrued over the last six decades in over 40 clinical articles and numerous other publications on ocular surface health, several key areas require further study. The comparison between studies is difficult due to elements that go beyond common factors, such as the indication for surgery, the reconstructive technique preferred by the surgeon or the availability of reconstructive materials. However, the differences in reporting style adopted by different authors between similar studies and the lack of data found in retrospective studies add to this complexity. The present review is divided into three parts. One covers the use of autologous materials for reconstruction and corneal transplants, as well as corneal clarity. A second part focuses on biomaterials and keratoprosthetics, while the third part focuses on the use of corneal sutures and report of ocular discomfort/pain in the veterinary literature. The review focuses on the main findings of each reconstruction technique. It aims to identify areas where key information about common procedures is missing so that general guidelines may be provided for the planning of patient record keeping and future retrospective or prospective studies, while it also aims to highlight the presence of knowledge gaps that deserve further attention.
- Open Access
- 15 September 2024
- Published by Wiley in Veterinary Ophthalmology
- Vol. 28 (2) , 403-412
Coronofrontal rhytidectomy: A new approach for the treatment of severe pseudoptosis and superior entropion in dogs
Purpose: To describe the use of coronofrontal rhytidectomy (CFR) for the treatment of severe pseudoptosis and superior entropion in dogs, and to provide guidelines for the selection of surgical technique depending on presentation.Methods: A review of medical records of dogs that underwent rhytidectomy from 2002 to 2023 was carried out, including signalment, clinical signs, type of rhytidectomy, concurrent surgical techniques, re‐interventions, post‐operative complications, follow‐up time, and outcome.Results: Twenty dogs with a median age of 5.1 years were included in this study. English Cocker Spaniel was the most common breed (8 dogs:40%) and males were overrepresented (13 dogs: 65%). Besides pseudoptosis and visual impairment (100%), the other most common clinical signs were entropion and/or ectropion (19 dogs: 95%), conjunctivitis (17 dogs: 85%), euryblepharon (12 dogs: 60%) and non‐ulcerative keratitis (10 dogs: 50%). CFR was performed in 12 dogs (60%), frontal rhytidectomy in 5 (25%), coronal in 2 (10%), and modified shared in 1 (5%). Concurrent surgical techniques were performed in 17 dogs (85%), being lateral canthoplasty (13 dogs; 65%), and Celsus–Hotz (10 dogs; 50%) the most common. The median follow‐up time was 115 days with no complications and good outcomes reported in all dogs. At last re‐recheck, complete correction of the eyelid positioning was obtained in 92% (11/12) and 87.5% (7/8) of the cases that underwent CFR and other rhytidectomy techniques, respectively.Conclusion: CFR is an effective surgical treatment for severe pseudoptosis and superior entropion in dogs. The provided guidelines will assist in the selection of the most appropriate eyelid lifting technique.
- 15 September 2024
- Published by Wiley in Veterinary Ophthalmology
- Vol. 28 (2) , 403-412
Open AccessCoronofrontal rhytidectomy: A new approach for the treatment of severe pseudoptosis and superior entropion in dogs
Purpose: To describe the use of coronofrontal rhytidectomy (CFR) for the treatment of severe pseudoptosis and superior entropion in dogs, and to provide guidelines for the selection of surgical technique depending on presentation.Methods: A review of medical records of dogs that underwent rhytidectomy from 2002 to 2023 was carried out, including signalment, clinical signs, type of rhytidectomy, concurrent surgical techniques, re‐interventions, post‐operative complications, follow‐up time, and outcome.Results: Twenty dogs with a median age of 5.1 years were included in this study. English Cocker Spaniel was the most common breed (8 dogs:40%) and males were overrepresented (13 dogs: 65%). Besides pseudoptosis and visual impairment (100%), the other most common clinical signs were entropion and/or ectropion (19 dogs: 95%), conjunctivitis (17 dogs: 85%), euryblepharon (12 dogs: 60%) and non‐ulcerative keratitis (10 dogs: 50%). CFR was performed in 12 dogs (60%), frontal rhytidectomy in 5 (25%), coronal in 2 (10%), and modified shared in 1 (5%). Concurrent surgical techniques were performed in 17 dogs (85%), being lateral canthoplasty (13 dogs; 65%), and Celsus–Hotz (10 dogs; 50%) the most common. The median follow‐up time was 115 days with no complications and good outcomes reported in all dogs. At last re‐recheck, complete correction of the eyelid positioning was obtained in 92% (11/12) and 87.5% (7/8) of the cases that underwent CFR and other rhytidectomy techniques, respectively.Conclusion: CFR is an effective surgical treatment for severe pseudoptosis and superior entropion in dogs. The provided guidelines will assist in the selection of the most appropriate eyelid lifting technique.
- Open Access
- 18 October 2023
- Published by Wiley in Veterinary Ophthalmology
- Vol. 27 (4) , 310-317
Follicular conjunctivitis in dogs: A retrospective study (2007–2022)
Objective: To evaluate the incidence, clinical features, treatment, and outcome of canine follicular conjunctivitis (CFC).Procedure: Medical records of dogs diagnosed with CFC were reviewed. Data recorded included signalment, duration of clinical signs and treatment details prior to presentation, concurrent ocular/systemic diseases, ocular clinical signs, cytology, treatment, follow‐up, and outcome. Blepharospasm, signs of self‐trauma, hyperemia, chemosis, ocular discharge, and follicle location and severity (0.5–4) were retrospectively evaluated. Based on severity, treatment consisted of topical 0.1% diclofenac or 0.1% dexamethasone sodium eyedrops. Dogs were classified into young (YD < 18 months) and adult (AD ≥ 18 months).Results: One hundred and fifty‐three dogs (276 eyes) were included in the study: 83YD (54%) and 70AD (46%). Males and bilateral disease were over‐represented in both groups. Severity was associated with young age (p = .032) and bilaterality (p = .025), and not with dermatological diseases (p > .05). No differences in follicular location were observed except for more frequent involvement of the nictitating membrane (MN) in YD (p = .02). Response to treatment was faster in AD (p = .001), with complete resolution in 80.6% of the eyes (100/124) at 1 month. YD treated with diclofenac showed faster resolution than those treated with 0.1% dexamethasone (p = .009).Conclusions: Although CFC is a bilateral ocular disease occurring at any age, the clinical presentation is influenced by age. Follicular conjunctivitis in adult dogs is less sever, less commonly affects the NM, and responds more quickly to topical treatment. One month of topical diclofenac may be adequate for mild cases, and 1 month of topical 0.1% dexamethasone is recommended as initial therapy for moderate to severely affected cases.
- 18 October 2023
- Published by Wiley in Veterinary Ophthalmology
- Vol. 27 (4) , 310-317
Open AccessFollicular conjunctivitis in dogs: A retrospective study (2007–2022)
Objective: To evaluate the incidence, clinical features, treatment, and outcome of canine follicular conjunctivitis (CFC).Procedure: Medical records of dogs diagnosed with CFC were reviewed. Data recorded included signalment, duration of clinical signs and treatment details prior to presentation, concurrent ocular/systemic diseases, ocular clinical signs, cytology, treatment, follow‐up, and outcome. Blepharospasm, signs of self‐trauma, hyperemia, chemosis, ocular discharge, and follicle location and severity (0.5–4) were retrospectively evaluated. Based on severity, treatment consisted of topical 0.1% diclofenac or 0.1% dexamethasone sodium eyedrops. Dogs were classified into young (YD < 18 months) and adult (AD ≥ 18 months).Results: One hundred and fifty‐three dogs (276 eyes) were included in the study: 83YD (54%) and 70AD (46%). Males and bilateral disease were over‐represented in both groups. Severity was associated with young age (p = .032) and bilaterality (p = .025), and not with dermatological diseases (p > .05). No differences in follicular location were observed except for more frequent involvement of the nictitating membrane (MN) in YD (p = .02). Response to treatment was faster in AD (p = .001), with complete resolution in 80.6% of the eyes (100/124) at 1 month. YD treated with diclofenac showed faster resolution than those treated with 0.1% dexamethasone (p = .009).Conclusions: Although CFC is a bilateral ocular disease occurring at any age, the clinical presentation is influenced by age. Follicular conjunctivitis in adult dogs is less sever, less commonly affects the NM, and responds more quickly to topical treatment. One month of topical diclofenac may be adequate for mild cases, and 1 month of topical 0.1% dexamethasone is recommended as initial therapy for moderate to severely affected cases.
- Open Access
- 1 January 2022
- Published by ScopeMed in Open Veterinary Journal
- Vol. 12 (1) , 138-147
Urrets-Zavalia syndrome following cataract surgery in dogs: A case series
In human medicine, Urrets-Zavalia syndrome (UZS) is a well-recognized but uncommon postoperative complication characterized by a fixed dilated pupil, accompanied by iris atrophy and glaucoma. Although it was originally reported in 1963 after penetrating keratoplasty surgery for keratoconus, it has been associated with various ophthalmic procedures such as cataract surgery. The condition has not been previously published in the veterinary literature. Three client-owned diabetic dogs that developed UZS´s triad after cataract surgery are described. Despite uneventful phacoemulsification in the six eyes, five developed moderate-to-severe postoperative ocular hypertension. Although intraocular pressure (IOP) spikes were initially controlled, fixed dilated pupils accompanied by iris atrophy and chronic ocular hypertension were seen in the five affected eyes. Aggressive medical and surgical management maintained vision in three of those eyes. In one eye, uncontrolled IOP led to blindness. This is the first published description of UZS in dogs, occurring after phacoemulsification. Although no exact, demonstrable causative element could be determined, we believe that should be considered a triggering condition for this syndrome, as it directly affects the ocular blood flow autoregulation and intrinsic uveal tissue integrity. Until the contrary is proved, diabetes mellitus might be considered as a risk factor for developing this syndrome after cataract surgery in dogs.
- 1 January 2022
- Published by ScopeMed in Open Veterinary Journal
- Vol. 12 (1) , 138-147
Open AccessUrrets-Zavalia syndrome following cataract surgery in dogs: A case series
In human medicine, Urrets-Zavalia syndrome (UZS) is a well-recognized but uncommon postoperative complication characterized by a fixed dilated pupil, accompanied by iris atrophy and glaucoma. Although it was originally reported in 1963 after penetrating keratoplasty surgery for keratoconus, it has been associated with various ophthalmic procedures such as cataract surgery. The condition has not been previously published in the veterinary literature. Three client-owned diabetic dogs that developed UZS´s triad after cataract surgery are described. Despite uneventful phacoemulsification in the six eyes, five developed moderate-to-severe postoperative ocular hypertension. Although intraocular pressure (IOP) spikes were initially controlled, fixed dilated pupils accompanied by iris atrophy and chronic ocular hypertension were seen in the five affected eyes. Aggressive medical and surgical management maintained vision in three of those eyes. In one eye, uncontrolled IOP led to blindness. This is the first published description of UZS in dogs, occurring after phacoemulsification. Although no exact, demonstrable causative element could be determined, we believe that should be considered a triggering condition for this syndrome, as it directly affects the ocular blood flow autoregulation and intrinsic uveal tissue integrity. Until the contrary is proved, diabetes mellitus might be considered as a risk factor for developing this syndrome after cataract surgery in dogs.
- 5 January 2021
- Published by Wiley in Veterinary Ophthalmology
- Vol. 24 (2) , 169-176
Safety and efficacy of unilateral topical application of rocuronium bromide in healthy scops owls (Otus scops)
Objective: To evaluate the safety and efficacy of unilateral topical application of rocuronium bromide in scops owls.Animals studied: Ten healthy adult scops owls.Procedures: Birds weighting between 82‐111 g were enrolled. Complete physical and ophthalmic examinations were performed. Each animal received a single dose of 0.15 mg of rocuronium bromide (30 µL) in a randomly selected eye. Static pupillometric evaluations were performed before and after drug instillation at 0, 30, 60, 90, and 120 minutes, in a room with fixed light intensity. Physical and ophthalmic examinations were carried out to evaluate possible adverse effects.Results: Median pupil (95% CI) size att0was 7.10 mm (5.51‐7.41) for placebo eyes and 7.22 mm (6.93‐7.48) for treated eyes, showing no statistical differences (P > .05). When compared to the placebo eye, significant mydriasis was achieved att30[8.18 mm (7.22‐9.00)] (P = .014) and lasting untilt90[7.35 mm (6.20‐9.52)] (P = .004). Maximal mydriasis was obtained att60[8.63 mm (7.72‐9.81)] (P = .001). During this period, the treated eye no longer responded to direct light stimulation. Complete mydriasis was observed in 5/10 birds (mean weight 97.4 g). Pupil size att90andt120did not differ from baseline (P > .05) in treated eyes. No adverse effects were seen during the study period.Conclusion: Single‐dose topical rocuronium bromide (0.15 mg) is a safe and effective medium duration mydriatic agent in scops owls. Further studies are needed to evaluate bilateral topical application and standardize the mydriatic protocol.
- 5 January 2021
- Published by Wiley in Veterinary Ophthalmology
- Vol. 24 (2) , 169-176
Safety and efficacy of unilateral topical application of rocuronium bromide in healthy scops owls (Otus scops)
Objective: To evaluate the safety and efficacy of unilateral topical application of rocuronium bromide in scops owls.Animals studied: Ten healthy adult scops owls.Procedures: Birds weighting between 82‐111 g were enrolled. Complete physical and ophthalmic examinations were performed. Each animal received a single dose of 0.15 mg of rocuronium bromide (30 µL) in a randomly selected eye. Static pupillometric evaluations were performed before and after drug instillation at 0, 30, 60, 90, and 120 minutes, in a room with fixed light intensity. Physical and ophthalmic examinations were carried out to evaluate possible adverse effects.Results: Median pupil (95% CI) size att0was 7.10 mm (5.51‐7.41) for placebo eyes and 7.22 mm (6.93‐7.48) for treated eyes, showing no statistical differences (P > .05). When compared to the placebo eye, significant mydriasis was achieved att30[8.18 mm (7.22‐9.00)] (P = .014) and lasting untilt90[7.35 mm (6.20‐9.52)] (P = .004). Maximal mydriasis was obtained att60[8.63 mm (7.72‐9.81)] (P = .001). During this period, the treated eye no longer responded to direct light stimulation. Complete mydriasis was observed in 5/10 birds (mean weight 97.4 g). Pupil size att90andt120did not differ from baseline (P > .05) in treated eyes. No adverse effects were seen during the study period.Conclusion: Single‐dose topical rocuronium bromide (0.15 mg) is a safe and effective medium duration mydriatic agent in scops owls. Further studies are needed to evaluate bilateral topical application and standardize the mydriatic protocol.